High-dose intravenous human immunoglobulin in polymyositis resistant to treatment.

Two patients were treated with treatment-resistant polymyositis with intravenous immunoglobulin over four days at a dose of 0.4 g/kg/day. Clinical recovery followed within two months. Serum creatine kinase (CK) activity decreased to normal, and a clear improvement in muscle strength was observed. On...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Neurol Neurosurg Psychiatry
Asıl Yazarlar: Jann, S, Beretta, S, Moggio, M, Adobbati, L, Pellegrini, G
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 1992
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC488936/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1372349/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.55.1.60
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller